Breathe

What the vendor page documents

Breathe is a plant-based respiratory formula marketed for mucus clearance, easier breathing and fewer wheezing episodes. It is presented by Elizabeth Moffett, described as a registered respiratory therapist (RRT) and certified asthma educator (AE-C) from Kentucky, and the page says the formula was developed with her.

Six ingredients are named: mullein, thyme leaf (Thymus vulgaris), peppermint oil and peppermint leaf, ginger, lemon peel and manuka honey. No milligram amount is published for any of them, and the page does not clearly state the format: the offer sells "bottles" and "30-day supplies", while the copy describes a "morning breathing ritual" that "takes less than 10 seconds a day". A buyer should confirm whether this is a capsule, a spray, a powder or a device.

Pricing is one bottle at $69 plus $9.95 shipping, three bottles at $59 each ($177) and six bottles at $49 each ($294), with free US shipping on the larger packs. The vendor states a 180-day money-back guarantee — one of the longest in our catalog — and the offer says all orders are one-time purchases only. The page does not display a numeric star rating.

What the page promises

The page is a long story about "stuck mucus" and "catalytic carbon", described as a modern toxin that coats the airways and causes wheezing, chest tightness and breathlessness. The formula is said to "dismantle mucus fortresses", "soothe and relax" the airways and "supercharge" the lungs' natural cleaning system.

There is a real mechanism underneath the language: mucus hypersecretion and impaired mucociliary clearance matter in chronic bronchitis, COPD and asthma. The page does not link a trial of Breathe itself, does not publish doses, and does not define "catalytic carbon" in a way a reader can check. It also describes conventional mucus thinners critically — saying guaifenesin "can wreak havoc on the body", irritate the stomach and cause "rebound" — without citing evidence for those statements. Readers who rely on guaifenesin should keep using it as directed and discuss any change with their clinician.

The ingredient sections cite published studies for thyme (including a trial in acute bronchitis with improvement over about 11 days), mullein and peppermint. Those are studies of individual herbs, often as teas or extracts, not of this product. The two testimonials (Joshua Brooks and Olivia Reed) describe rapid clearance and better exercise tolerance; they are not verified with dates or purchase records.

What the ingredients are studied for

• Thyme has the best evidence here. Small trials of thyme-based preparations in acute bronchitis show reduced cough and mucus compared with placebo. The effect is modest and short-term.
• Mullein is a traditional demulcent herb for cough and throat irritation. Human trials are small and old; it is not an established mucus dissolver.
• Peppermint (menthol) provides a cooling sensation and may ease the perception of congestion. It does not remove mucus, and peppermint oil should not be applied near the face of infants.
• Ginger has anti-inflammatory and antioxidant properties; respiratory outcome data are limited.
• Lemon peel provides flavonoids and vitamin C. It is a pleasant antioxidant, not a lung cleanser.
• Manuka honey has antibacterial activity in laboratory studies and is used in wound care. Evidence for airway "remodelling" from an oral supplement is limited.

The formula is thyme-forward, and thyme is the ingredient with the most relevant human data. The detox framing around "catalytic carbon" is a story that goes beyond the herbal evidence; the herbs themselves are familiar and generally well tolerated.

Safety and who should be cautious

• Breathlessness, chest pain, coughing blood, fever or blue lips need urgent care. Do not rely on a supplement during an asthma attack or COPD exacerbation.
• Do not stop inhalers, steroids or prescribed mucus thinners without talking to your clinician. Guaifenesin is a standard, well-studied expectorant.
• Asthma and COPD: any add-on should be discussed with your clinician, especially if you use controller medication.
• Mint and reflux: peppermint can worsen acid reflux. Honey: avoid in infants under 12 months and monitor glucose if you have diabetes.
• Allergy: thyme, mint and citrus can trigger reactions in sensitive people.
• Pregnancy and breastfeeding: herbal blends are not established as safe; ask a professional.
• Format: confirm what the product is before use so the directions can be followed correctly.

Who it may suit — and who it may not

Breathe may suit an adult with mild, stable mucus and cough symptoms who has been assessed by a clinician, wants a thyme-based herbal option alongside standard care, and values the 180-day refund. It may not be the best fit for anyone with asthma, COPD or a current infection, anyone who needs a rescue inhaler, anyone advised to use guaifenesin, or anyone who wants to know the format and dose before buying.

Our lung health category lists what we track, including Pulmo Balance. The comparison tool only pairs products in the same category, and our supplement safety checklist lists the questions worth asking. The methodology page explains how missing doses and an unclear format affect the score.

What to verify before buying

1. The format and directions — capsule, spray, powder or device.
2. Milligram amounts for all six ingredients — none are published on the page.
3. The 180-day terms — confirm who pays return shipping.

How the score treats this product

The score reflects the documented 180-day guarantee, the one-time purchase, the six named ingredients and the capture date. The unpublished doses, the unclear format and the absence of a product-specific trial limit the disclosure component. The two testimonials are shown with their source, not scored. The result is a comment on disclosure and commercial terms, not a medical judgment.

Sources

• Breathe official page (captured 2026-11-09)
• National Heart, Lung, and Blood Institute — COPD
• NCCIH — Thyme
• MedlinePlus — Guaifenesin
• MedlinePlus — Mullein

Editorial content by the ViaReviews Research Team, last reviewed 2026-11-09. Informational only, not medical advice.